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Abstract
The proteins, tissue plasminogen activator (t-PA) and plasminogen activator inhibitor 1 (PAI-1), act in concert to balance
thrombus formation and degradation, thereby modulating the development of arterial thrombosis and excessive bleeding.
PAI-1 is upregulated by the renin-angiotensin system (RAS), specifically by angiotensin II, the product of angiotensin
converting enzyme (ACE) cleavage of angiotensin I, which is produced by the cleavage of angiotensinogen (AGT) by renin
(REN). ACE indirectly stimulates the release of t-PA which, in turn, activates the corresponding fibrinolytic system. Single
polymorphisms in these pathways have been shown to significantly impact plasma levels of t-PA and PAI-1 differently in
Ghanaian males and females. Here we explore the involvement of epistatic interactions between the same polymorphisms
in central genes of the RAS and fibrinolytic systems on plasma t-PA and PAI-1 levels within the same population (n = 992).
Statistical modeling of pairwise interactions was done using two-way ANOVA between polymorphisms in the ETNK2, RENIN,
ACE, PAI-1, t-PA, and AGT genes. The most significant interactions that associated with t-PA levels were between the ETNK2
A6135G and the REN T9435C polymorphisms in females (p = 0.006) and the REN T9435C and the TPA I/D polymorphisms
(p = 0.005) in males. The most significant interactions for PAI-1 levels were with REN T9435C and the TPA I/D polymorphisms
(p = 0.001) in females, and the association of REN G6567T with the TPA I/D polymorphisms (p = 0.032) in males. Our results
provide evidence for multiple genetic effects that may not be detected using single SNP analysis. Because t-PA and PAI-1
have been implicated in cardiovascular disease these results support the idea that the genetic architecture of cardiovascular
disease is complex. Therefore, it is necessary to consider the relationship between interacting polymorphisms of pathway
specific genes that predict t-PA and PAI-1 levels.
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Introduction
Preventing excessive blood loss following vessel injury is
controlled through a process known as hemostasis. The tight
regulatory mechanisms of hemostasis manage this response to
prevent thrombus formation. One mechanism involved in this
balance is fibrinolysis, the physiological breakdown of fibrin, an
essential component of blood clots. Upon release of the serine
protease tissue plasminogen activator (t-PA) from vascular
endothelial cells, circulating plasminogen is cleaved to produce
plasmin, a proteolytic enzyme responsible for the degradation of
fibrin [1]. The fibrinolytic pathway is also partially regulated by
the renin-angiotensin system; this has been demonstrated by
studies that show pharmacological inhibition of the angiotensin
converting enzyme (ACE) indirectly stimulates release of t-PA [2]
while reducing levels of its inhibitor, plasminogen activator
inhibitor-1 (PAI-1) [3]. Other studies have found comparable
effects of the renin-angiotensin system (RAS) on both t-PA and
PAI-1, a connection that may be modulated by genetic variation in
both systems [2,4–6]. Clinical evidence indicates that plasma
concentrations of t-PA and PAI-1 can also serve as biomarkers of
first myocardial infarction [7,8], atherosclerosis [9], ischemic
stroke [10] and ischemic heart disease [11].
In the present study, polymorphisms have been selected from
genes in the renin-angiotensin and fibrinolytic pathways to assess
the genetic contribution to the protein concentrations of t-PA and
PAI-1 in a large-scale population-based cohort; this study
supplements the available literature that is primarily based on
high-risk populations. To this end, we have designed complemen-
tary population based studies in the Netherlands and Ghana
[12–17]. In prior analysis of the Ghanaian sample inter-individual
variation in plasma levels of t-PA and PAI-1 was associated with
conventional cardiovascular risk factors including body mass index
(BMI), blood pressure, cholesterol, glucose and triglycerides
[16,17]. Additionally, genetic analyses revealed statistically
significant associations between polymorphisms in the RAS genes
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as well as t-PA and PAI-1 on plasma concentrations of the t-PA
and PAI-1 proteins. This univariate analysis demonstrated that t-
PA and PAI-1 concentrations are influenced by both traditional
cardiovascular risk factors as well as genetic polymorphisms and
that these factors differ between females and males [16]. The
current study was conducted to explore the role of two-way
epistatic interaction effects on the plasma levels of the t-PA and
PAI-1 proteins based on polymorphisms in genes from the renin-
angiotensin and fibrinolytic pathways in a large-scale population-
based sample from urban West Africa, and to assess whether such
analyses are significantly more informative than single SNP
analyses. The hypothesis of interaction among these genes/
markers is not only supported by previous statistical work [13], but
by data on protein-protein interactions [18].
Materials and Methods
Study Population
The population-based sample from urban West Africa analyzed
in this study has been described previously [17]. In summary,
participants were enrolled by word-of-mouth in Sunyani, Ghana,
the capital city of the Brong-Ahafo region (n= 992) regardless of
chronic disease status. Exclusion criteria comprised age less than
18 years, prior enrollment of a first or second degree relative, and
indication of acute illness that could impact t-PA or PAI-1 levels.
Women represented 57.3% of the sample. Protocols and consent
forms were approved by both U.S. and Ghanaian authorities in
accordance with the Declaration of Helsinki.
Laboratory Measurements
Blood samples were collected for measurement of fasting
glucose, lipids, t-PA and PAI-1 levels by commercially available
assays, protocols have been described elsewhere [17]. The t-PA
and PAI- 1 measures will be discussed here in brief. To address
circadian rhythm derived variability in t-PA and PAI-1 protein
concentrations, all blood samples were collected between 8:00 and
10:00 am. Day-to-day variability in these proteins was not
addressed in the current study. Blood was collected in Biopool
Stabilyte tubes (Umea, Sweden) and chilled on ice briefly before
centrifugation at 3000 Gs and 0uC for 20 minutes. Plasma was
then transferred under sterile conditions into cryotubes and
immediately stored in liquid nitrogen for shipment to Vanderbilt
University (Nashville, TN) in IATA approved Cryo shippers
(MVE products). Plasma t-PA and PAI- 1 levels were measured,
using a commercially available enzyme-linked immunoassay
(ELISA, Biopool AB, Umea, Sweden).
Measurement of Genetic Polymorphisms
DNA isolation was carried out on-site using PureGene DNA
purification kits (Gentra Systems). Polymorphisms were detected
using TaqMan probes and PCR primers designed through the
Assays-by-Design service of Applied Biosystems. TaqMan SNP
Genotyping Assays were processed and analyzed according to the
manufacturer’s recommendations with an ABI 7900 HT Fast Real
Time PCR system and the SDS 2.0 genotype calling software
(Applied Biosystems), respectively. The nine polymorphisms
genotyped are listed in Table 1. Due to a rare genotype, rs5186
(MAF =0.02), was excluded from the analysis. The eight
remaining polymorphisms were used for the interaction analyses.
The variants selected for this study included two polymorphisms
in the renin gene (REN), two polymorphisms in the ethanolamine
kinase gene (ETNK2), and one in each of the angiotensinogen
(AGT), ACE, t-PA and PAI-1 genes. Note that although ETNK2
is not expected to affect fibrinolytic balance per se, the SNPs in this
gene were chosen because ETNK2 is less than 5 KB from REN,
and these may represent or tag variants in REN or variants that
affect REN expression. All of these genes have been associated
with cardiovascular endpoints or as functional variants associated
with plasma PAI-1 and t-PA concentrations [16]. Also, these SNPs
were analyzed because they are the same ones previously reported
in our single marker analysis and their analyses allowed direct
comparison of the single SNP to two SNP analyses [16].
Statistical Analysis
Baseline characteristics for continuous and categorical data have
been reported as mean 6 standard deviation and as group
percentages, respectively. Comparisons of continuous characteris-
tics between males and females were done using the Student’s t
test. Comparisons of categorical characteristics between males and
females were done with the x2 test. The baseline characteristics of
the population-based sample are provided in Table 2. It has been
demonstrated previously that anthropometric, metabolic and
genetic factors show statistically significant variation between the
sexes, as such, further analyses have been carried out in males and
females separately [16].
The purpose of the statistical analysis in the current study was to
assess the role combinations of genetic polymorphisms, within the
renin-angiotensin and fibrinolytic pathways, play in the prediction
of plasma t-PA and PAI-1 levels. The null hypothesis being tested
is that the effect of any single polymorphism on t-PA and PAI-1
plasma levels is independent of the effects of any other
polymorphism. To test the null hypothesis we used two-way
analysis of variance (ANOVA) to calculate an interaction term.
The dependent variable (t-PA or PAI-1) has been natural log
transformed for all analyses for normalization as previously
reported [16]. The results were considered statistically significant
if the p-value was less than or equal to 0.05 and marginally
significant at the 0.10 level. Both thresholds were considered
evidence toward rejection of the null hypothesis in favor of the
alternative hypothesis of epistasis or gene-gene interaction effects.
In addition, we calculated r2 values of the interaction term in each
statistically significant model as an estimate of the amount of
variability explained by the SNP pairs. All tests were carried out in
males and females separately as the distribution of PAI-1 have
been previously shown to be sex specific [12,16].
More specifically, all genotypes were coded to allow for
assessment of additive effects (AA =0, Aa = 1, aa = 2), dominant
effects (AA = 0, Aa = 0, aa = 1) and recessive effects (AA = 0, Aa
= 1, aa = 1). Using ANOVA, all 28 possible pairs of genotypes (all
combinations of 8 choose 2) were evaluated for nine possible
interaction effects including additive by additive, additive by
dominant, additive by recessive, dominant by additive, dominant
by dominant, dominant by recessive, recessive by additive,
recessive by dominant and recessive by recessive. In total, 970
tests were performed. After adjusting for missing genotypes
following the conversion of the genotype coding to account for
the various interaction effect models, 243 tests were carried out in
females per phenotype and 242 tests were carried out in males per
phenotype. We set three thresholds of significance for making
inferences about the epistatic effects of the polymorphisms. First,
we use an uncorrected significance level of a=0.10 to indicate
suggestive evidence for an interaction. This liberal threshold was
set as an exploratory cut-off with consideration for the known role
that the pathways and genes included in this study play in t-PA
and PAI-1 biochemistry and the likelihood that the chosen
polymorphisms are strong candidates. Second, we use an
uncorrected significance level of a=0.05 to indicate evidence for
an interaction. Our most stringent condition is a significance level
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of a=0.025. This significance threshold represents a correction for
the different genetic models tested and was derived from 1000
Monte Carlo simulations under the null hypothesis and has been
described elsewhere [13]. Results for all tests are reported in the
supplementary material so that interpretation of statistical
significance as it relates to biological significance can be assessed
by the reader. Corrections were not made for multiple testing
among variants since there is clear biological evidence that each
pathway represented by the candidate SNPs in this study is
involved in the regulation of t-PA and PAI-1 expression either
directly or indirectly meaning that the universal null hypothesis of
association by random chance does not apply [19]. Additionally,
since ANOVA has more power to detect independent main effects
than interactions effects for this exploratory analysis we are more
concerned with type II errors (false-negatives) than type I errors
(false-positives).
As the final step in this study we selected a subset of the results
containing the 112 most significant interaction pairs (i.e. 28
possible genotype pairs by sex and phenotype) to create a new data
set of minimum p-values from the set of different genotype
codings. Because we selected for rare or extreme events we would
not expect these data to follow a normal distribution. As such, this
subset of the results was modeled by fitting the generalized
extreme value distribution. The parameters of this distribution are
location, scale, and shape. Using the maximum likelihood
estimates of these parameters from the model we calculated the
probabilities of getting the observed p-values for the most
significant interacting pairs of SNPs. This analysis was carried
out in R using the package extremes (http://cran.rproject.org/
web/packages/extRemes/index.html).
Results
A summary of the results are presented as network diagrams in
Figures 1, 2, 3, 4. The most significant findings are illustrated
without redundancy, meaning that if the same two SNPs in
combination met our threshold criteria under different models
(e.g. DxA and DxR) that SNP combination was only represented
one time.
In females, we found significant interaction effects between
polymorphisms in various components of the renin-angiotensin
pathways predictive of plasma t-PA levels. Of the 28 pairwise
combinations tested, 8 interactions met our significance criteria
(Figure 1 and Table S1). The most significant of these gene-gene
interactions occurred between the ETNK2 A6135G variant and
the REN T9435C variant (p = 0.006, r2 = 1.82%), but the largest
r2 was for an interaction between markers REN T9435C and
ETNK2 A6135G (p= 0.011, r2 = 2.27%) (Table S2). We also
found significant interaction effects between polymorphisms in
various components of the renin-angiotensin pathways predictive
of plasma PAI-1 levels. Of the 28 pairwise combinations tested, 8
interactions met our significance criteria (Figure 2 and Table S3).
The most significant of these gene-gene interactions occurred
between the REN T9435C variant and the TPA I/D variant
Table 1. Genotyped polymorphisms.
Gene rs Chromosome Position1
Minor
Allele Minor Allele Frequency
Angiotensin converting enzyme (ACE I/D) rs4646994 17 61565904 I 0.43
Angiotensin II receptor, type 1 rs5186 3 148459988 C 0.02
Angiotensinogen (AGT M235T) rs699 1 230845794 A 0.08
Ethanolamine kinase 2 (ETNK2 C5047T) rs2293337 1 204115934 T 0.15
Ethanolamine kinase 2 (ETNK2 A6135) rs1917542 1 204114846 G 0.40
Renin (REN T9435C) rs3730103 1 204125987 C 0.33
Renin (REN G6567T) rs1464816 1 204128854 T 0.36
t-PA (TPA I/D) rs4646972 8 42039905 I 0.36
PAI-1 (PAI 4G/5G) rs1799768 7 100769706 4G 0.20
The angiotensin II receptor, type 1 polymorphism was excluded from interaction analyses due to low minor allele frequency of the rare allele.
1Build 37.1.
doi:10.1371/journal.pone.0016639.t001
Table 2. Baseline characteristics.
Characteristic Females Males p-value{
(n =569) (n =423)
Age (years) 42.7610.9 44.0612.7 0.074
Height (cm) 16266.33 17267.04 ,0.001
Weight (kg) 70.2614.7 70.7612.9 0.550
BMI
(kg/m2)
26.665.34 23.864.15 ,0.001
Current
Smoking
0.00% 3.10% ,0.001
SBP
(mmHg)
126618.9 132620.8 ,0.001
DBP
(mmHg)
77.3610.5 78.0613.0 0.380
Glucose
(mg/dl)
94.5624.7 91.5621.1 0.051
Total
cholesterol
(mg/dl)
182642.7 170645.4 ,0.001
Triglycerides
(mg/dl)*
4.3460.509 4.4260.542 0.006
t-PA
(ng/ml)*6
1.8060.667 1.7860.805 0.690
PAI-1
(ng/ml)*
1.2761.33 1.0361.49 0.008
Participants were enrolled by word-of-mouth in Sunyani, Ghana, the capital city
of the Brong-Ahafo region (n = 992).
*indicates ln transformed value.
doi:10.1371/journal.pone.0016639.t002
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(p = 0.001, r2 = 1.98%)(Table S2). Interactions occurring between
REN T9435C and TPA I/D, REN T9435C and PAI 4G/5G, as
well as TPA I/D and PAI 4G/5G were significant for both t-PA
and PAI-1 levels in females (Figures 1 and 2). It is of note that for
all models presented the r2 for the interaction term accounted for
the majority of the variance explained in the full model (Table S2).
In males, we found significant interaction effects between
polymorphisms in various components of the renin-angiotensin
pathways predictive of plasma t-PA levels. Of the 28 pairwise
combinations tested, 11 interactions met our significance criteria
(Figure 3 and Table S4). The most significant of these gene-gene
interactions occurred between the TPA I/D variant and the REN
T9435C variant (p = 0.005, r2 = 1.80%) (Table S2). The largest r2
for t-PA was for an interaction between markers TPA ID and
PAI-1 4G5G (p= 0.025, r2 = 2.62%)(Table S2). We also found
significant interaction effects between polymorphisms in various
components of the renin-angiotensin pathways predictive of
plasma PAI-1 levels. Of the 28 pairwise combinations tested, 4
met our significance criteria (Figure 4 and Table S5). The most
significant of these gene-gene interactions occurred between the
TPA I/D variant and the REN G6567T variant (p = 0.032,
r2 = 1.08%) (Table S2). Interactions occurring between ACE I/D
intron 16 and ETNK2 A6135G, ETNK2 A6135G and REN
G6567T, ETNK2 A6135G and PAI 4G/5G, as well as TPA I/D
and REN G6567T were associated with both t-PA and PAI-1
levels in males.
Figure 1. Network diagrams to summarize the results of the statistical analysis of epistasis between polymorphisms within the
renin-angiotensin and fibrinolytic systems on the levels of t-PA in the plasma of females. Three levels of statistical significance are
represented in these figures, suggestive evidence where p,0.10, denoted by dotted lines, evidence where p,0.05, denoted by dashed lines and
strong evidence where p,0.025, denoted by solid lines. The * symbol indicates results that have been validated by extreme value analysis. When the
same pairs were statistically significant under various genotype codes (e.g. additive by additive vs. dominant by additive) only the most significant
result was chosen for display in the network diagrams to visually simplify the plots. Female REN G6567T genotypes have previously been shown to
associate with t-PA in single gene analyses.
doi:10.1371/journal.pone.0016639.g001
Figure 2. Network diagrams representing polymorphism interactions predictive of plasma t-PA in males. Figure is as described for
figure 1. TPA I/D and REN G6567T genotypes in males have previously been shown to associate with t-PA in single gene analyses.
doi:10.1371/journal.pone.0016639.g002
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Focusing on the results displayed in the network plots (Figures 1,
2, 3, 4) we can compare the interactions found to predict t-PA and
PAI-1 levels across the sexes. The female and male data revealed
the following common interacting partners in the analyses for t-
PA: ETNK2 A6135G and ETNK2 C5047T, ETNK2 A6135G
and PAI 4G/5G, REN T9435C and TPA I/D, in addition to
TPA I/D and PAI 4G/5G. Interaction pairs common to females
and males in the PAI-1 analyses included: ETNK2 A6135G
interacting with REN G6567T and TPA I/D interacting with
REN G6567T.
While some of the interactions are shared between the sexes,
there are also many differences. For example, we have strong
evidence supporting an interaction effect of ETNK2 A6135G
and REN T9435C on plasma t-PA levels in females (p = 0.006)
while there is no supporting evidence in males (p = 0.613).
Similarly, we see strong evidence for an interaction effect of
REN G6567T and AGT M235T on plasma t-PA levels in males
(p = 0.008) but not in females (p = 0.496). The same is true when
considering the strong evidence in support of an interaction
effect between TPA I/D and REN T9435C on plasma levels of
Figure 3. Network diagrams representing polymorphism interactions predictive of plasma PAI-1 in females. Figure is as described for
figure 1. Female PAI 4G/5G genotypes have previously been shown to associate with PAI-1 in single gene analysis.
doi:10.1371/journal.pone.0016639.g003
Figure 4. Network diagrams representing polymorphism interactions predictive of plasma PAI-1 in males. Figure is as described for
figure 1. Male ETNK2 A6135G, TPA I/D, and REN G6567T genotypes have previously been shown to associate with PAI-1 in single gene analysis.
doi:10.1371/journal.pone.0016639.g004
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PAI-1 in females (p = 0.001) compared to that in males
(p = 0.971).
It is also of interest to examine the structure of these
interactions. Interaction plots of the most significant findings
for each sex and phenotype pair are presented in Figure 5.
Additional plot information including sample size and
confidence intervals is presented in Table S6. The deviations
from parallel in these plots indicate that, in all cases, the
protein levels of both t-PA and PAI-1 depend on genotype
combinations and not single SNP status, in other words,
epistatic interactions.
Here we have described and illustrated the 31 most significant
gene-gene interactions. However, a total of 86 of the 970 tests were
significant or marginally significant (p,0.10). Of the most
significant models three were characterized as dominant-dominant
interactions, five were characterized as dominant-additive inter-
actions, eleven were characterized as dominant-recessive interac-
tions, one was characterized as an additive-additive interaction,
seven were characterized as recessive-additive interactions, and
the remaining four were characterized as recessive-recessive
interactions.
Discussion
The fibrinolytic system maintains balance through a series of
enzymatic reactions, regulating the dissolution of thrombi. The
principal regulators of the system are t-PA and its primary
inhibitor PAI-1. Furthermore, crosstalk exists between the
fibrinolytic pathway and the renin-angiotensin pathway providing
an additional layer of regulation. In this study we investigated the
effects of epistatic interactions, between polymorphisms within
genes of t-PA, PAI-1 and the renin-angiotensin system, on the
plasma concentration of the t-PA and PAI-1 proteins. Our results
support the idea that the genetic architecture underlying
cardiovascular disease is complex and requires consideration of
multiple interacting polymorphisms in concert to reliably predict
the levels of associated proteins, t-PA and PAI-1.
In a previously published study we reported that anthropomet-
ric, metabolic, and genetic cardiac risk factors, in this population,
are sex-dependent [16]. Although we did not consider covariates
in the present study, we chose to carry-out the analyses separately
for females and males because one of the dependent variables,
PAI-1 levels, was one of the factors that differed between the sexes.
Figure 5. Interaction plots showing the most significant interacting polymorphisms in association with the natural log-transformed
values. A) t-PA in males with t-PA I/D and REN C9435T genotypes; B) t-PA in females with ETNK2 A6135G and REN C9435T; C) PAI-1 in males with REN
G6567T and t-PA I/D; D) PAI-1 in females with REN C9435T and t-PA I/D. These plots reflect the mean log transformed protein levels observed for the
individual polymorphism combinations where deviation from parallel between the lines indicates dependency. Actual values are given in Table S6.
doi:10.1371/journal.pone.0016639.g005
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We also wanted to maintain consistency between this analysis and
the prior studies based not only on this population, but also those
based on a cohort from the Netherlands. As expected, we found
supporting evidence for male-female differences in the underlying
genetic factors predictive of t-PA and PAI-1 plasma concentra-
tions. In fact, the majority of interactions were sex specific. This
result is consistent with the results of an epistasis analysis done with
population data from the Netherlands where similar genetic
differences were found to be predictive of t-PA and PAI-1 levels for
each sex [13].
Evaluation of all pairwise combinations of the eight measured
polymorphisms revealed many statistical interactions involving
polymorphisms within the renin-angiotensin system, as well as
interactions involving polymorphisms between the renin-angio-
tensin system and polymorphisms in the t-PA or PAI-1 genes.
Because this was an exploratory analysis we tested the 28
possible pairwise interactions per sex and phenotype combina-
tion across each of the 9 interaction models but selected only the
single best model per interacting pair. We chose not to correct
for multiple testing but instead to validate our findings by using
extreme value analysis. We found that 15 of the 31 observed p-
values representing pairwise interactions had a probability of
less than 10% while 5 of the observed p-values had a probability
of less than 5%. Based on these results we believe that at a
minimum these 15 pairwise interactions represent true statistical
epistasis. These validated interactions coincide with the most
statistically significant results illustrated in Figures 1, 2, 3, 4. It is
of note that when compared to the single SNP analyses where
only 5 of the 8 variants were shown to individually associate
with t-PA and/or PAI-1 concentrations, even with liberal
statistical criteria [16], we found that all 8 variants were
significant in the 2-locus analyses. For example, REN T9435C
and ETNK2 A6135G were predictive of female t-PA levels
together but neither SNP alone showed association. Based on
these results it is reasonable to conclude that these interactions,
involving polymorphisms lacking an independent main effect,
will be necessary to inform complete genotype to phenotype
mapping.
In addition to reporting p-values we have also reported r2
values for all statistically significant interacting partners. These
values serve as an estimate of the amount of variability
explained by each interaction in each model. Our two-locus
interaction terms explain as much as 2.6% of the variability in
protein levels, but even these modest effect sizes are larger than
those of the single SNP analyses (less than 1.3%, [16].
Interestingly, we often see the highest r2 values for interactions
among pairs of SNPs that were not individually associated with
either plasma t-PA or PAI-1. For example, the interaction
between REN T9435C and ETNK2 A6135G in females
predicts t-PA levels with a p-value of 0.010 and a corresponding
r2 value of 2.27%, but neither SNP alone showed an association
with female t-PA levels. One exception to this observation is the
evaluation of male t-PA levels where TPA I/D (p = 0.026,
r2 = 1.20%) and REN T9435C (p = 0.019, r2 = 1.30%) do show
individual associations, but, notably, when combined in a two-
way model the correlation becomes stronger (p = 0.002,
r2 = 4.45% for the full model and p = 0.016, r2 = 1.92% for
the interaction alone). If these two SNPs had independent main
effects on t-PA levels we would expect the r2 value of the two-
way model to equal the sum of the individual r2 values. It is
important to note that the complete genetic model will likely
include main effects, numerous gene-gene and gene-environ-
ment interactions Nonetheless, in some cases we are able to
explain more than 2% of the variability in protein levels just by
focusing on two-locus interaction terms. This underscores the
necessity of considering gene-gene interactions when studying
common human phenotypes/diseases.
The variants ETNK2 A6135G, REN G6567T, TPA I/D, and
PAI 4G/5G, were the most frequently observed in our models,
appearing in all of the network diagrams. Of these variants
ETNK2 A6135G is involved in the most statistically significant
interactions. The ETNK2 gene codes for a protein that catalyzes
the first reaction the CDP-ethanolamine pathway, resulting in
production of the major membrane lipid phosphatidylethanol-
amine (PtdEtn), this gene was chosen not for its function but
because it is located on chromosome 1q32 near the renin gene and
may include alternative promoter regions for renin. It is known
that ETNK2 2/2 mice often have failed fetal development at the
late stages of pregnancy due to extensive placental thrombosis,
suggesting a critical role for ETNK2 sequences in hemostasis [20].
Another commonly appearing variant also supported in the
literature, in association with PAI-1 levels, is the PAI 4G/5G
variant. This polymorphisms shows a functional role in basal
transcription levels of PAI-1 associating with increased PAI-1
plasma levels [21,22].
By evaluating all pair wise combinations of these polymor-
phisms for association with t-PA and PAI-1 protein levels we have
begun to assess the contribution statistical epistasis plays in
defining genetic risk factors of cardiovascular disease. And because
these genes have good prior evidence for biological interaction
[2,3], the results, even when considering multiple testing, provide a
plausible scenario for the regulation of PAI-1 and tPA. However,
we recognize that these results do not permit us to draw
conclusions regarding biological function or causation because
statistical epistasis at the population level and biological epistasis at
the individual/biochemical levels are not identical [23]. Never-
theless, we have shown that, at the population level, pairs of
polymorphisms consistently provide more information on t-PA
and PAI-1 protein levels than any single polymorphism, and these
pairwise combinations provide testable hypotheses that can be
addressed experimentally. Taken together these results support the
hypothesis that genetic architecture of cardiovascular risk is
complex, but can be elucidated.
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